.png)
In 2024, Cryo-Cell International reached a pivotal milestone with the opening of its state-of-the-art, 56,000-square-foot facility in Durham, North Carolina. This advanced space not only increases Cryo-Cell's storage capacity by more than tenfold but also serves as the new home for all long-term stem cell storage moving forward. This transition ensures clients’ stem cell specimens continue to be safeguarded in a cutting-edge, secure environment.
A Vision for the Future
This new facility signifies more than just expansion—it represents Cryo-Cell's commitment to innovation in stem cell preservation and biotechnology. By creating a robust infrastructure designed for both cryogenic storage and advanced biotech operations, Cryo-Cell is setting a new standard in the industry.
Facility Overview
Cryo-Cell has designed and equipped its Durham facility to meet the highest standards in cryogenic storage, safety, and operational efficiency. The building has defined spaces, one of which is a dedicated cryogenic storage area, for Cryo-Cell’s new biopharma storage subsidiary, ExtraVault. Cryo-Cell has successfully relocated many of its clients’ dewars containing stored stem cell specimens to the Durham site. Clients have been notified of this transition, ensuring a seamless experience.
Introducing ExtraVault: A Premier Third-Party Biobank Storage Solution
Cryo-Cell is leveraging its expertise to offer high-quality third-party biobank storage services under the ExtraVault brand. This service is designed for academic centers, biopharma companies, and transplant centers that require secure and accredited cryogenic storage solutions.
ExtraVault Key Features:
Cutting-Edge Cryogenic Storage
- Equipped with multiple rows of double-jacketed, vacuum-insulated steel pipes for liquid nitrogen (LN2) distribution.
- A massive 13,000-gallon LN2 storage tank ensures uninterrupted cryogenic conditions.
- Storage capacity for over 200 large LN2 dewars.
Advanced Safety Systems
- Three independent oxygen (O2) monitoring systems protect facility personnel in case of a nitrogen leak.
- Safety features include:
- Automatic shutoff for LN2 tank flow.
- Central monitoring system alerts staff to any irregularities.
- Seven O2 monitors connected to the HVAC system, which automatically increases airflow to dilute LN2 in the air if needed.
Additional Storage Options
Reliable Power and Emergency Systems
- 300kW natural gas generator ensures backup power for uninterrupted operations.
- Plans are in place to increase generator capacity to 1.3mW as growth occurs.
- Automatic fire suppression sprinkler system for additional protection.
Expanding Capabilities Beyond Storage
As the Durham facility reaches full operational status, Cryo-Cell will integrate additional services that reinforce its expertise in biotech innovation and cellular therapy. The 11,000 square feet of clean room space set aside for advanced biologic manufacturing, as well as an additional 11,000 square feet of clinical trial space, broadens Cryo-Cell’s role in regenerative medicine and clinical research.
With FACT and AABB accreditations and membership in the National Marrow Donor Program (NMDP), Cryo-Cell maintains the highest standards for specimen storage and preservation. These credentials underscore its commitment to regulatory compliance and industry best practices.
Durham Facility and Oldsmar Headquarters: A Dual Commitment
Cryo-Cell’s primary laboratory remains at its headquarters in Oldsmar, Florida where all specimens will be processed. Long-term storage will be at Durham, NC facility. The Oldsmar location and its staff continue to be actively involved in research collaborations and partnerships, ensuring that Cryo-Cell maintains its leadership position in both stem cell preservation and scientific advancement.
A Commitment to the Future
Cryo-Cell’s new Durham facility embodies the company’s commitment to long-term security and scientific advancement. As the company continues to push the boundaries of stem cell banking and biotechnology, its mission remains clear: to protect and preserve life-saving stem cells while pioneering new advancements in medical science.